Key Takeaways
- Supply shock reshapes the quarter: A fire at a major competitor's plant in late May tightened domestic BOPET/BOPP supply and lifted margins, but the benefit arrived too late to save Q1; full impact is expected in subsequent quarters.
- Volume-led revenue, margin still lagging: Revenue rose ~6.5% YoY to ₹3,922 crores on 7.9% volume growth, yet EBITDA margin slipped to 12% from 12.7% as tariff uncertainty and customer pre-stocking weighed on overseas operations.
- Aseptic packaging expansion delayed again: The long-awaited capacity ramp from 7 to 1,200 crore packs, originally expected January 2025, is now pushed to early H2 FY26; FY26 volume guidance cut to 850-900 crore packs from ~1,000 crore.
- CAPEX-heavy thesis intact but back-end loaded: Management reiterated that ~₹2,000 crores of projects will add ~₹3,000 crores revenue and ~₹600 crores EBITDA at peak utilization, but nearly all benefit lands only in FY27.
- What to watch next quarter: Whether the Jindal fire-driven margin uplift materializes in reported numbers, how quickly Nigeria and Poland utilization recovers from tariff-related destocking, and any concrete commissioning date for the aseptic expansion.
The Jindal Fire: A Supply-Side Inflection
- What happened: In the third week of May, a very large packaging film player suffered an accident at its plant. Exports from India to Europe dropped, local availability of BOPET and BOPP films tightened, and the demand-supply balance improved, driving better margins post-event.
- Asymmetric impact by substrate: The margin uplift is more profound in BOPP than in BOPET, because higher imports from Southeast Asia and China checked PET price increases. Traders who had stocked material incurred losses as domestic players adjusted prices downward.
- Europe gets pricing power: Indian film exports to Europe declined in June versus May and are likely to keep falling, which should give European operations (Poland, Hungary) pricing power in subsequent quarters. Poland was hurt earlier by Indian exports into Europe; that trend reversed from June.
- India film division tailwind: The domestic market dynamics changed for the better post-incident, and India is expected to do better in coming quarters.
- The cycle risk embedded in the opportunity: Management cautioned that whenever margins increase, every industry player declares they should add a line, which could recreate overcapacity in three years.
Rajesh Bhatia: "a very large player in the packaging film industry had an accident at its plant and that changed the industry dynamics a bit"
Overseas Operations: Tariff Turbulence
- Nigeria worst hit: Capacity utilization dropped sequentially because US customers had stocked well in advance before a 19% tariff was imposed (up from 10% reciprocal duty earlier). UFlex chose to keep volumes low while the situation settles.
- Poland squeezed by Indian exports: Poland was impacted by Indian film exports into Europe; this reversed from June onward as Indian exports declined post-fire, which should restore pricing power.
- Mexico holds a tariff hedge: 70% of Mexico's production is exported to North America, largely the US, and a large part is covered under USMCA with nil duty as of now. If duties apply on all other nations, UFlex gains an edge and scope for better margins on Mexico-to-US exports.
- Dubai and Hungary mixed: Dubai saw no significant impact beyond a plant shutdown during the period; Hungary did well both sequentially and YoY. Egypt also improved sequentially.
- US demand muted in Q1: Tariff anticipation caused customers to stock films in advance, leading to hesitation on new orders and muted North American demand. Management expects the tariff situation to settle over the next two quarters before final plans are clear.
Rajesh Bhatia: "a large part of our exports from Mexico to US are covered under USMCA and there is a nil duty as of now. And if that remains so, that will ultimately give us an edge over the other countries who were selling to US"
Aseptic Packaging: Delayed Again, Guidance Cut
- The delay: Expansion from 7 to 1,200 crore packs was expected to start from January 2025 but did not happen. Commissioning is now expected anytime soon, latest early H2 FY26.
- Why the delay barely matters for FY26: Even if commissioned immediately, the aseptic business follows a calendar-year cycle tied to the juice season; meaningful revenue and profitability contribution will only come from January 2026 onward.
- Guidance reset: Full-year FY26 volume guidance revised to 850-900 crore packs, down from the earlier ~1,000 crore packs. The Q1 miss of 50-70 crore packs is expected to be recovered in Q4.
- Egypt greenfield on track: A separate 1,200 crore pack greenfield expansion in Egypt is likely to be commissioned in FY26, though product approval timelines mean benefit will be limited this year.
Rajesh Bhatia: "even if it gets done tomorrow itself, it is not going to give you any additional revenue than the profitability as of now"
CAPEX Pipeline: Heavy, Back-End Loaded
- The headline promise: Total planned CAPEX of ~₹2,000 crores across aseptic packaging, WPP bags, CPP film in Mexico, Sanand debottlenecking, and Noida recycling is expected to add ~₹3,000 crores in revenue and ~₹600 crores in EBITDA at 85% capacity utilization.
- The timeline catch: Benefit of all projects except Sanand expansion will be available only in FY27. Sanand expansion starts contributing from January 2026. The Egypt aseptic plant may get some benefit sooner but product approval takes time.
- Balance spend: ~₹900 crores of CAPEX remains to be spent in the current year and Q1 FY27.
- Debt peak then decline: Net debt-to-EBITDA will rise to a maximum of 4.0-4.1x, then fall below 3x as new projects commission and profitability kicks in. Interest on project borrowings is capitalized as part of project cost.
- Recycling: a patience play: The 40,000-ton Noida recycling facility will be ready by year-end and stands to benefit from government mandates requiring 30% recycled content in rigid packaging and 10% in flexible packaging. But management calls it a game of patience: regulations take time to stabilize, and real traction may take 1-2 extra years. UFlex is offering a single-pellet solution (70% virgin, 30% recycled) to simplify customer adoption under EPR rules.
Rajesh Bhatia: "But I think it is a game of patience because the government is doing this, now see this is the first year, next year when the government will audit it or people will file their returns then it will be known how they are taking this thing, how they are doing it."
Margins & Costs: Pressure Points
- EBITDA margin slipped to 12% from 12.7% YoY. India did well, but tariff uncertainties and customer pre-stocking caused a drag. Management calls it a passing phase and expects margins to improve in subsequent quarters on the supply-side change from the competitor accident.
- Fixed-cost stickiness: Employee costs and power & fuel costs appeared elevated relative to revenue because volumes reduced due to Trump tariffs and local factors. These are mostly fixed or semi-fixed and cannot be trimmed for a one-quarter volume dip. Management reviews manpower periodically but sees nothing to worry about.
- BOPET margins have bottomed out but were checked this quarter by higher imports from Southeast Asia and China. It will take at least two more years before any meaningful demand-supply balancing in BOPET.
- Flexible packaging margins improved YoY with good volume growth. Strategy is to move up the value chain into pouches and reduce low-value-added products, though additional volumes will be limited because no investment has been made in this segment in recent years.
- Other operating income is largely business income: export incentives and scrap sales, very much part of operational income.
Industry Structure & Competitive Dynamics
- BOPP capacity cycle risk: SRF, Nahar, and Dhunseri are adding BOPP capacity in India. No other global capacity additions are planned in the remaining three quarters. But management warns that the industry has a pattern: whenever margins rise, everyone adds a line, which could recreate overcapacity in three years.
- Import threat and industry response: Higher imports from Southeast Asia and China kept BOPET prices in check this quarter. The industry is pushing for BIS implementation on packaging films to ensure local industry remains viable.
- Virgin PET chips rationale: The plant was originally planned during COVID when raw material availability was challenging. It now gives certainty of raw material quality and price. In Panipat, bottle-grade chips have delivered better margins for two quarters, so UFlex buys raw material externally and makes bottle-grade chips.
Rajesh Bhatia: "We have seen that whenever some margins increase then everyone who is there in the industry everyone says that I should also make one line at least. Like everyone has done last time, if this happens like that then again, we will go to overcapacity in the next three years."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 10% YoY increase; remaining three quarters need ~11% growth, partly volume but largely pricing | FY26 |
| EBITDA | ~₹2,100 crores (vs ~₹1,900 crores in FY25) | FY26 |
| Aseptic packaging volume | 850-900 crore packs (revised from ~1,000 crore packs) | FY26 |
| Aseptic expansion commissioning | Latest early H2 FY26; revenue benefit only from January 2026 | Early H2 FY26 |
| Egypt aseptic greenfield commissioning | Likely in FY26; product approval takes additional time | FY26 |
| Film division production | ~132,000 tons per quarter | FY26 quarterly run-rate |
| CAPEX balance spend | ~₹900 crores | FY26 and Q1 FY27 |
| Net debt-to-EBITDA peak | 4.0-4.1x, then declining below 3x as projects commission | Peak during project phase |
| CAPEX project revenue/EBITDA contribution | ~₹3,000 crores revenue, ~₹600 crores EBITDA at 85% utilization | FY27 (bulk of benefit) |
| Sanand expansion benefit | From January 2026 | January 2026 onward |
| Noida recycling facility | Ready by end of year; regulatory traction may take 1-2 extra years | Facility: FY26; benefit: gradual |
| Nigeria and Poland utilization recovery | Expected to sort out | Next couple of quarters |
| US tariff situation clarity | Needs to settle before final plans are clear | Next two quarters |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue | ₹3,922 cr, up ~6.5% YoY |
| Volume growth | 7.9% YoY, excluding PET resin sales |
| Packaging films volume growth | 6.8% YoY |
| Packaging (flexible) volume growth | 11.7% YoY |
| EBITDA margin | 12.0%, down from 12.7% in Q1 FY25 |
| Exceptional forex loss | Nil, versus ~₹180 cr in Q1 FY25 |
| Flexible Packaging volume growth | 7.4% YoY |
| Liquid Packaging volume growth | 18% YoY |
| Asepto volume | 230 cr packs, Q1 FY26 |
| Asepto FY26 volume guidance | 850–900 cr packs, revised from ~1,000 cr packs |
| Film division production volume | 127,900 tons, Q1 FY26 |
| Film division quarterly production guidance | ~132,000 tons per quarter |
| India PET resin capacity utilization | 97% |
| Egypt PET resin capacity utilization | ~75% |
| Net debt-to-EBITDA | 3.90x, expected to peak at 4.1x |
| Total debt | ₹7,300 cr |
| CAPEX spent as of June 30 | ~₹1,100 cr out of ~₹2,000 cr approved |
| FY26 revenue growth guidance | 10% YoY; Q1 grew 6.4%, remaining 3 quarters need ~11% growth |
| FY26 EBITDA guidance | ~₹2,100 cr, versus ~₹1,900 cr in FY25 |
| New projects potential revenue | ~₹3,000 cr at ~85% utilization |
| New projects potential EBITDA | ~₹600 cr, implying ~20% margin |
| BOPP gross value-added margin | ~35% over raw material cost |